mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |